Abstract 570: Preclinical insights into 161Tb-trastuzumab and immune checkpoint combination therapy for cancer in a HER2-expressing murine cancer modelSigrid Cold, Lotte K. Kristensen, Emma Papin et al.|Cancer Research|2025Cited by 0